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Abstract. Depression is psychosomatic disorder are common in patients with chronic kidney 
disease (CKD) undergoing hemodialysis (HD). Correlated with morbidity and mortality 
associated with chronic inflammation in patients, that characterized by elevated levels of 
plasma cytokines, especially interleukin (IL)-6. Objective: To investigate the correlation of 
depressive symptoms with IL-6 levels in patients with CKD who underwent regular HD. 
Methods: One hundred and 29 CKD patients were enrolled in this cross-sectional study. All 
eligible patients were screened for IL-6 level. Beck Depression Inventory (BDI) II questioner 
were then given to determine the presence of depression. Level of IL-6 was then correlated 
with BDI score using Spearman test. Result: The mean BDI score was 19,32 ± 6,18 indicating 
the level of mild depression symptoms, and the mean IL-6 level (8,697 ± 6,947 pg/mL) was 
still within normal range. There was a moderate positive correlation (r = 0.417) between the 
level of depressive symptoms and IL-6 levels. Conclusion: There was a moderate positive 
correlation (r = 0.417) between IL-6 levels and depressive symptoms in patient with HD. 
However, mean IL-6 levels in depressive patients are still within normal limits indicating that 
the cause of depression is multifactorial. 
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1. Introduction 
Depression is a condition known as mood disorder, such as feelings of sadness, despair, guilt, 
even lead to suicidal desires [1]. Patients with CKD who underwent HD often suffer from 
depression [2]. Taraz et al study showed that 20% - 40% of the population undergoing HD suffer 
from depression, psychosocial and environmental factors (such as loss of work, lack of social 
support and dialysis) make the patient vulnerable to depression [3]. Depression in HD patients is 
associated with morbidity and mortality. This is associated with chronic inflammation 
characterized by elevated plasma levels of proinflammatory cytokines, specifically interleukin 
(IL)-6.4 IL-6 has a strong predictive value compared with CRP in the HD patient.5,6 In several 
studies, there was no significant difference IL-6 levels between patient with and without 
depressive symptoms. But there is also several studies that suggests depression is positively 
correlated with IL-6 levels [3]. The underlying molecular mechanism is associated with increased 
activity of the HPA-axis [7]. Thus, IL-6 has a role in coordinating important biological pathways 
in depression [8]. This study aims to see whether there is a correlation of the level of depressive 
symptoms with IL-6 levels in CKD patients undergoing regular HD. 
2. Methodology 
This is cross-sectional analytical study with the sample size of 159 people. This study was 
conducted on subjects who had signed informed consent. The research was conducted in HD Unit 
of H Adam Malik and Pirngadi Medan Hospital with the approval of research commission of 
Research Faculty of USU, conducted from July 2017 - August 2017. The research begins with 
literature search, title consultation, proposal preparation, proposal seminar, research and data 
analysis preparation of reports that take up to 1 month. Research subject are male or female aged 
18-69 years suffering from CKD according to K/DOQI criteria undergoing HD >3 months, in 
stable condition, able to speak Bahasa Indonesia and understand the contents of the questionnaire, 
able to communicate well, get informed and give consent to participate in voluntary and written 
research (informed concern). This research has received permission from Ethical clearance 
obtained from Medical Research Committee Faculty of Medicine Universitas  Sumatera Utara. 
The subjects will be excluded if the patient with malignancy, acute infection, using NSAID or 
glucocorticoid, refusing to be interviewed and not willing to take blood. Of the 159 subjects, 58 
patients were aligible and willing to take part in the study. Blood sampling for IL-6 was performed 
using the Human IL-6 Immunoassay (R & D system) examination procedure. Blood sample was 
taken before HD procedure. Serum IL-6 was measure by Enzim-linked immunosorbent assay 
(ELISA). Serum IL-6 value is considered normal if the value 0-20 pg/mL. During hemodialysis 
procedure the patient was asked to fill out the BDI II questionnaire filled for ± 10 minutes.  BDI 
is a self-report questionnaire, created by Beck et al. used to measure the attitudes and 
characteristics of depressive symptoms. The questionnaire consists of 21-item, 15 items referring 
to psychological-cognitive symptoms, while the remaining 6 items refer to somatic vegetative 
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symptoms. Based on the depression scores are classified into; score 0-13 without symptoms of 
depression, score 14-19 showed symptoms of mild depression, score 20-28 symptoms of 
moderate depression, score 29-63 symptoms of major depression [11]. subjects who did not suffer 
depression were excluded. Demographic data were obtained from questionnaires. Clinical data 
were obtained from the medical record. Analysis of the basic characteristics of population data 
used tabulation to show descriptive description. To see the data normality test used Shapiro-Wilk 
test. The correlation of depressive symptom level with IL-6 level were analyzed using Spearman 
correlation test. Data were analyzed using SPSS statistics program for Windows, version 18.0 
(SPSS Inc., Chicago, Illinois, USA); with p value <0.05 considered statistically significant. 
 
Figure 1. Flowchart of Patients In The Study 
 
3. Result 
Of the 159 participants, 47 patients included in the study consist of 25 men and 22 women (Figure 
1). Characteristics based on age, CKD sufferers are generally> 40 years old (80.9%), with more 
male (53.2%), high school education (59.6%), and junior high (4,3%), most of employment is 
self-employed / private employee as much as 46,8%, followed by housewife (31,9%) and lowest 
pensioner 8,5% and marital status almost 97,9% married. Based on the etiology of CKD with the 
most hypertensive nephropathy (HN) (59,6%) followed by diabetic nephropathy (DN) (19,1%) 
and lowest with Chronic Glomerulonephritis (8,5%) and the highest level of depression symptoms 
were mild depression (61,7%), moderate depression as many as 23.4% and the lowest severe 
depression (14.9%) (Table 1). 
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Table 1. Characteristics of Subjects of Patients with Ckd with Depression 
Characteristics Patients Frequency 
(n) 
Percentage % 
Age (years)   
≤40 
>40 
 
9 
38 
19,1 
80,9 
Sex   
Male 
Female 
25 
22 
53,2 
46,8 
Education   
Primary School 
Junior High School 
Senior High School 
College 
5 
2 
28 
12 
10,6 
4,3 
59,6 
25,5 
Occupation   
Government employees 
Employees entrepneur 
Pensionary 
Housewife 
6 
22 
4 
15 
12,8 
46,8 
8,5 
31,9 
Marriage   
Married 
Single 
46 
1 
97,9 
2,1 
Etiology CKD   
HN 
DN 
Obstructive Kidney Disease 
Chronic Glomerulonephritis 
28 
9 
6 
4 
59,6 
19,1 
12,8 
8,5 
Level of depression   
Mild 
Moderate 
Severe 
29 
11 
7 
61,7 
23,4 
14,9 Total 47 100% 
 
CKD patients with depression had mean IL-6 levels 8,697 ± 6.947 pg / mL, indicating that they 
were still within normal limits. Based on the assessment of depressive symptom level using BDI 
scores, the mean value of BDI score was 19.319 ± 6.182 indicating the level of mild depression 
symptoms (Table 2). 
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Table 2. Mean Levels of Il-6 and Depression Scores 
Results IL-6 BDI 
n 47 47 
Mean 8,697 19,319 
Std. Deviation 6,947 6,182 
Minimum 1,481 14 
Maximum 28,881 38 
 
From this study showed that the correlation of IL-6 level with depressive symptom level had 
correlation coefficient value 0.417 and p value <0.05. This explains that there is a significant 
positive correlation of IL-6 levels with depression levels with moderate correlation strength 
(Figure 2). 
Figure 2. Correlation of Depression Symptoms with Il-6 Levels 
4. Discussion 
Depression is one of the most common psychosomatic problems in patients with CKD. The 
prevalence of depression in CKD patients varies widely in different studies, in different 
populations using different assessment tools [9,10]. The results of this study found the highest 
rates of depressive symptoms were mild depression symptoms (61.7%) and the lowest is severe 
depression (14.9%). In contrast to research conducted by Thomas et al using the Zung Self-rating 
Sumatera Medical Journal (SUMEJ) Vol. 01, No. 01, 2018  24                                                         																																																							
Depression Scale (ZSDS) method to assess the level of depressive symptoms in patients with 
CKD with the highest prevalence was moderate depression (76.47%) [10]. 
Characteristics of the subjects of this study were CKD sufferers who underwent regular 
hemodialysis with frequency depression most prevalent in men (53.2%) aged> 40 years (80.9%). 
This is in accordance with the results of a study reported by Amira in Nigeria using a cross-
sectional study that assessed the prevalence of depressed symptoms in patients with CKD with 
the highest frequency was men 73 people (61.9%) with an average age of 40, 3 ± 12.1 years [9]. 
However, the frequency of males in depressed patients is inconsistent with the theory according 
to WHO [11] and research conducted by Deshpande et al. in India which states that depression is 
more common in women. According to research Deshpande et al women are more susceptible to 
stress, especially in the family, prolonged stress causes women to be more sensitive to problems 
relationships at home or workplace [12]. This may be due to the higher progression of CKD in 
men than in women [12,13]. 
In this study the mean IL-6 levels (8.697 ± 6.947 pg / mL) were still within normal limits with 
depressive symptoms using BDI scores with a mean score of 19.319 ± 6.182 indicating mild 
depressive symptoms may be due to depression in patients with hemodialysis CKD multifactorial. 
Not only is it caused by IL-6 alone but it can also be caused due to extrinsic factors such as 
psychosocial stressors, environmental and dialysis and intrinsic factors such as uremia that often 
occur in patients with CKD2. However, in this study the mean IL-6 levels increased significantly 
as the rate of depressive symptoms increased and these findings were consistent with meta-
analysis studies conducted by Dowlati et al which showed IL-6 was significantly higher in the 
depressed group than in the control group [14]. 
From the results of this study found that based on Spearman correlation test showed a significant 
positive correlation between the level of depressive symptoms with IL-6 levels in CKD patients 
undergoing regular hemodialysis, with moderate correlation strength (r = 0.417). This suggests 
that in CKD patients undergoing regular hemodialysis, increased rates of depressive symptoms 
will be followed by elevated levels of IL-6 by moderate degree. This is in line with research 
conducted by Hung et al with a cross-sectional study of 146 CKD patients who underwent regular 
hemodialysis every three times a week for 3 months. In a study by Hung et al. which assessed the 
correlation of depressive symptoms using a BDI questionnaire with IL-6 levels with the results 
found a significant positive correlation between BDI and IL-6 levels in CKD patients undergoing 
regular hemodialysis, with moderate correlation strength (r = 0.47) [15]. Similar results were also 
conducted by Bob et al that assessed the correlation of BDI II with IL-6 concentration with IL-6 
result significantly positive correlation with BDI II (r = 0.47, p <0.01) [16]. 
In contrast to the research conducted by Uglešić et al.17 who assessed the correlation of 
depressive symptoms with IL-6 levels in patients with CKD with hemodialysis every 3 times a 
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week, compared with patients with continuous ambulatory peritonel dialysis (CAPD). Depression 
symptoms were assessed using a BDI score with the results of a correlation of depressive 
symptoms with IL-6 levels in CKD patients with CAPD with strong correlation strength (r = 
0.58), and no correlation between depressive symptoms and IL-6 levels in patients with 
hemodialysis. The low correlation between BDI score and IL-6 levels in the study was suspected 
because in many hemodialysis patients were exposed to several inducing factors such as contact 
with the dialysis membrane, endotoxin contamination and non-endotoxin-inducing factors that 
could interfere with the correlation [17].  
The limitations of this study are cross-sectional research designs which are only possible to 
determine the relationship between variables and not causal relationships. Some important aspects 
for depression assessment such as family history, social life background are not evaluated. 
Symptoms of anxiety and measures of quality of life are also not assessed because it is not the 
main focus of this study. 
In conclusion, there was a positive correlation with moderate strength (r = 0.417) between the 
level of depressive symptoms and IL-6 levels in CKD patients with regular hemodialysis. 
However, mean IL-6 levels in depressive patients are still within normal limits indicating that the 
cause of depression is multifactorial. 
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